ADAT Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ADAT Antibodies for studying adenosine deaminase acting on tRNA (ADAT). ADAT Antibodies are available for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ADAT plays a crucial role in the post-transcriptional modification of tRNA, specifically in the deamination of adenosine to inosine, which is essential for proper tRNA function and protein synthesis. The modification process significantly influences cellular processes, including gene expression regulation and response to stress. Understanding ADAT functionality provides insights into various biological pathways and potential implications in diseases. Researchers can effectively track ADAT localization and interactions within cellular environments using advanced detection methods. Multiple validation studies have demonstrated consistent and reliable results across different experimental conditions. Characterization of ADAT's molecular mechanisms has revealed its significance in maintaining cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies for ADAT research support scientists in advancing our understanding of tRNA biology and its impact on human health.